Motor neuron diseases (MND) are a heterogeneous group of disorders that includes amyotrophic lateral sclerosis (ALS) and result in death of motor neurons. These diseases may produce characteristic perturbations of the metabolome, the collection of small-molecules (metabolites) present in a cell, tissue, or organism. To test this hypothesis, we used high performance liquid chromatography followed by electrochemical detection to profile blood plasma from 28 patients with MND and 30 healthy controls. Of 317 metabolites, 50 were elevated in MND patients and more than 70 were decreased (p<0.05). Among the compounds elevated, 12 were associated with the drug Riluzole. In a subsequent study of 19 subjects with MND who were not taking Riluzole and 33 healthy control subjects, six compounds were significantly elevated in MND, while the number of compounds with decreased concentration was similar to study 1. Our data also revealed a distinctive signature of highly correlated metabolites in a set of four patients, three of whom had lower motor neuron (LMN) disease. In both datasets we were able to separate MND patients from controls using multivariate regression techniques. These results suggest that metabolomic studies can be used to ascertain metabolic signatures of disease in a non-invasive fashion. Elucidation of the structures of signature molecules in ALS and other forms of MND should provide insight into aberrant biochemical pathways and may provide diagnostic markers and targets for drug design.
Similar content being viewed by others
References
M. Beal R. Ferrante S. Browne R. Matthews N. Kowall R. Brown (1997) ArticleTitleIncreased 3-Nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis Ann. Neurol 42 644–654 Occurrence Handle10.1002/ana.410420416 Occurrence Handle9382477
G. Bensimon L. Lacomblez V. Meininger (1994) ArticleTitleA controlled trial of Riluzole in amyotrophic lateral sclerosis N. Engl. J. Med 330 585–591 Occurrence Handle10.1056/NEJM199403033300901 Occurrence Handle8302340
W. Beuche M. Yushchenko M. Mader M. Maliszewska K. Felgenhauer F. Weber (2000) ArticleTitleMatrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis Neuroreport 11 3419–3422 Occurrence Handle11095490
M. Bogdanov R.H. Brown W. Matson R. Smart D. Hayden H. O’Donnell M. Flint Beal M. Cudkowicz (2000) ArticleTitleIncreased oxidative damage to DNA in ALS patients Free Radic. Biol. Med 29 652–658 Occurrence Handle10.1016/S0891-5849(00)00349-X Occurrence Handle11033417
J. Brindle H. Antti E. Holmes G. Traner J. Nicholson H. Bethell S. Clarke P. Schofield E. McKilling D. Mosedale D. Grainer (2002) ArticleTitleRapid and non-invasive diagnosis of the presence and severity of coronary hear disease using 1H-NMR-based metabonomics Nat. Med 8 1439–1444 Occurrence Handle10.1038/nm802 Occurrence Handle12447357
J. Brindle J. Nicholson P. Schofield D. Grainger E. Holmes (2003) ArticleTitleApplication of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension Analyst 128 32–36 Occurrence Handle10.1039/b209155k Occurrence Handle12572799
W. Camu M. Billiard M. Baldy-Moulinier (1993) ArticleTitleFasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis Acta Neurol. Scand 88 51–55 Occurrence Handle8372631
D. Cleveland J. Rothstein (2001) ArticleTitleFrom Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS Nat. Rev. Neurosci 2 806–819 Occurrence Handle10.1038/35097565 Occurrence Handle11715057
L. Eriksson E. Johansson N. Kettaneh-Wold S. Wold (2001) Multi and Megavariate Analysis: Principles and Applications Umetrics Umea
T.R. Golub D.K. Slonim P. Tamayo C. Huard M. Gaasenbeek J.P. Mesirov H. Coller M.L. Loh J.R. Downing M.A. Caligiuri C.D. Bloomfield E.S. Lander (1999) ArticleTitleMolecular classification of cancer: class discovery and class prediction by gene expression monitoring Science 286 531–537
S. Hadano C. Hand H. Osuga Y. Yanagisawa A. Otomo R. Devon N. Miyamoto J. Showguchi-Miyata Y. Okada R. Singaraja D. Figlewicz T. Kwiatkowski B. Hosler T. Sagie J. Skaung J. Nasir R.J. Brown S. Scherer G. Rouleau M. Hayden J. Ikeda (2001) ArticleTitleA gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 Nat. Genet 29 166–173 Occurrence Handle10.1038/ng1001-166 Occurrence Handle11586298
G.G. Harrigan R. Goodacre (Eds) (2003) Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis Kluwer Academic Publishers Boston
D.B. Kell (2004) ArticleTitleMetabolomics and system biology: making sense of the soup Curr. Opin. Microbiol 7 296–307 Occurrence Handle10.1016/j.mib.2004.04.012 Occurrence Handle15196499
R. Kennedy Y. Lee B. Roy Particlevan C. Redd R. Lippman (1997) Solving Data Mining Problems Through Pattern Recognition Prentice Hall PTR Indianapolis
B. Kristal K. Vigneeau-Callahan W. Matson (1998) ArticleTitleSimultaneous analysis of the majority of low-molecular weight, redox-active compounds from mitochondria Anal Biochem 263 18–25 Occurrence Handle10.1006/abio.1998.2831 Occurrence Handle9750137
B.S. Kristal K. Vigneau-Callahan W.R. Matson (2002) ArticleTitleSimultaneous analysis of multiple redox-active metabolites from biological matrices Meth. Mol. Biol 186 185–194
J. Kurtzke L. Kurland (1989) The epidemiology of neurologic disease R. Joynt (Eds) Clinical Neurology J.B. Lippincot Philadelphia 1–43
L. Lacomblez G. Bensimon P. Leigh P. Guillett V. Meininger (1996) ArticleTitleDose-ranging study of riluzole in amyotrophic lateral sclerosis Lancet 347 1425–1431 Occurrence Handle8676624
Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S., S.W. and et al. (2003). VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 34, 383–394
D.E. Lilienfeld E. Chan J. Ehland J. Godbold P.J. Landrigan G. Marsh D.P. Perl (1989) ArticleTitleRising mortality from motoneuron disease in the USA, 1962–84 Lancet 1 710–713 Occurrence Handle10.1016/S0140-6736(89)92218-6 Occurrence Handle2564517
J.C. Lindon E. Holmes J.K. Nicholson (2004) ArticleTitleMetabolomics and its role in drug development and disease diagnosis Expert Rev. Mo. Diagn 4 189–199 Occurrence Handle10.1586/14737159.4.2.189
B. Manley (1994) Multivariate Statistical Methods: A Primer EditionNumber2 CRC Press Boca Raton
W. Matson P. Langials L. Volicer P. Gamache E. Bird K. Mark (1984) ArticleTitleN-electrode three dimensional liquid chromatography with electrochemical detection for determination of neurotransmitters Clin. Chem 30 1477–1488 Occurrence Handle6147209
V. McGuire W. Longstreth T. Koepsell G. Belle Particlevan (1996) ArticleTitleIncidence of ALS in three counties in western Washington state Neurology 47 571–573 Occurrence Handle8757041
Milbury, P. (1997). CEAS generation of large multiparameter databases for determining categorical process involvement of biomolecules, Coulometric Array Detectors for HPLC, V.S.P. International Science, Utrecht, the Netherlands, pp. 125–141
H. Mitsumoto D. Chad E. Pioro (1998) Amyotrophic Lateral Sclerosis Oxford Press New York
J. K. Nicholson I. D. Wilson (2003) ArticleTitleUnderstanding ‘global’ systems biology: metabonomics and the continuum of metabolism Nat. Rev. Drug Discov 2 668–676 Occurrence Handle10.1038/nrd1157 Occurrence Handle12904817
I. Puls C. Jonnakuty B. LaMonte E. Holzbaur M. Tokito E. Mann M. Floeter K. Bidus D. Drayna S. Oh R. Brown C. Ludlow K. Fischbeck (2003) ArticleTitleMutant dynactin in motor neuron disease Nat. Genet 33 455–456 Occurrence Handle10.1038/ng1123 Occurrence Handle12627231
D. Rosen T. Siddique D. Patterson D. Figlewicz E. Sapp A. Hentati D. Donaldson J. Goto J. O’Reagan H. Deng (1993) ArticleTitleMutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature 362 59–62 Occurrence Handle10.1038/362059a0 Occurrence Handle8446170
Rothstein, J., Tsai, G., Kuncl, R., et al. (1990). Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 28, 18–25
L. Rowland N. Shneider (2001) ArticleTitleAmyotrophic lateral sclerosis N Engl. J. Med 344 1688–1700 Occurrence Handle10.1056/NEJM200105313442207 Occurrence Handle11386269
H. Shi K. Vigneau-Callahan W. Matson B. Kristal (2002) ArticleTitleAttention to relative response across sequential electrodes improves quantitation of coulometric array Anal. Biochem 302 239–245 Occurrence Handle10.1006/abio.2001.5568 Occurrence Handle11878803
E. Simpson J. Henkel Y. Henry R. Smith S. Appel (2003) ArticleTitleElevated levels of 4-HNE in the sera of patients wtih amyotrophic lateral sclerosis Neurology 60 A242
R. Smith Y. Henry M. Mattson S. Appel (1998) ArticleTitlePresence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis Ann. Neurol 44 696–699 Occurrence Handle10.1002/ana.410440419 Occurrence Handle9778272
J. Greef Particlevan der P. Stroobant R. Heijden Particlevan der (2004) ArticleTitleThe role of analytical sciences in medical systems biology Curr. Opin. Chem. Biol 8 559–565 Occurrence Handle10.1016/j.cbpa.2004.08.013 Occurrence Handle15450501
K. Vigneau-Callahan A. Shestopalov P. Milbury W. Matson B. Kristal (2001) ArticleTitleCharacterization of diet-dependent metabolic serotypes: I. Analytical and biological variability issues J Nutr 131 924S–932S Occurrence Handle11238787
Y. Yang A. Hentati H. Deng O. Dabbagh T. Sasaki M. Hirano W. Hung K. Ouahchi J. Yan A. Azim N. Cole G. Gascon A. Yagmour M. Ben-Hamida M. Pericak-Vance F. Hentati T. Siddique (2001) ArticleTitleThe gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis Nat. Genet 29 160–165 Occurrence Handle10.1038/ng1001-160 Occurrence Handle11586297
Author information
Authors and Affiliations
Corresponding author
Additional information
†S.R., M.E.C. and M.B. contributed equally to this work. W.R.M. and B.S.K. contributed equally to this work. S.R., M.B., W.R.M., B.S.K., C.B., S.H., P.V., M.F.B., and R.K-D. have financial interests in Metabolon Inc., a company engaged in metabolic profiling. ††Electronic supporting figures, tables and datasets are available at the Journal’s website.
*To whom corrsepondence should be addressed.E-mail: kaddu001@mc.duke.eduCurrent address: Duke University Medical Center, Department of Psychiatry, P.O. Box 3950, Durham, NC 27710.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Rozen, S., Cudkowicz, M.E., Bogdanov, M. et al. Metabolomic analysis and signatures in motor neuron disease. Metabolomics 1, 101–108 (2005). https://doi.org/10.1007/s11306-005-4810-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11306-005-4810-1